SANA Q2 2023 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$116M

Net Income

-$114M

EPS (Diluted)

$-0.59

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$59M

Free Cash Flow

-$60M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$707M

Total Liabilities

$352M

Stockholders' Equity

$355M

Cash & Equivalents

$174M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$116M	-$73M	-59.5%
Net Income	-$114M	-$72M	-57.3%